Acciones Axis-Shield Ltd

Acciones

Diferido London S.E. Otros sitios de cotización			Varia. Cinco días.	Varia. 1 de enero.
- ^GBX	-.--%		-.--%	-.--%

Duración

Período

Estilo

Axis Shield : The Effect of Food Intake on the Pharmacokinetics of Vadadustat Following Single Dose Administration	29/07/20
Axis Shield : Randomized, Double-Blinded, Active-Controlled (Darbepoetin Alfa), Phase 3 Study of Vadadustat in Chronic Kidney Disease Patients With Anemia on Hemodialysis in Japan	29/07/20
Axis Shield : Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia	29/07/20
Axis Shield : Targeted Literature Review of Patient-reported Burden of Anemia in Chronic Kidney Disease	29/07/20
Efficacy and Safety of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, Being Evaluated for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Japanese Subjects: Results from Phase 2 Studies (encore)	29/07/20

Axis-Shield Ltd es una empresa con sede en el Reino Unido. La empresa desarrolla, fabrica y comercializa productos de diagnóstico in vitro.

Sector

	Varia. 1 de ene.	Capi.
AXIS-SHIELD LTD	-.--%	0
BIOMÉRIEUX	-11,68 %	11,22 mil M
LANTHEUS HOLDINGS, INC.	+27,58 %	5482,63 M
DIASORIN S.P.A.	+1,44 %	5384,26 M
AUTOBIO DIAGNOSTICS CO., LTD.	-17,38 %	3765,68 M
ANDON HEALTH CO., LTD.	+8,12 %	2597,12 M
10X GENOMICS, INC.	-64,90 %	2351,07 M
VITROLIFE AB	-10,17 %	2246,5 M
MYRIAD GENETICS, INC.	+26,75 %	2195,72 M
GUANGZHOU WONDFO BIOTECH CO.,LTD	-12,53 %	1701,76 M